ReBio Technologies
ReBio Technologies, a biotech company, specializes in developing proprietary routes to key commodity platform biochemicals.
ReBio Technologies operates in biotechnology, health care, manufacturing based in Europe, Middle East, and Africa (EMEA), founded in 2014.
Within the biotechnology, health care, manufacturing space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Grant.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $5.5M in funding.
| Sector | Biotechnology, Health Care, Manufacturing |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2014 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $5,457,324 |
Website: rebiopharma.com
Sign in to view the contact information we hold for ReBio Technologies.
Create a free account
Create a free account